Stay updated with breaking news from Timely Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "COVID-19 Vaccines - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. According to the new...
Press release content from Business Wire. The AP news staff was not involved in its creation.
I urge my colleagues in Congress to take the first step to streamline the prior authorization process by quickly passing H.R. 3173, so that we can ensure that patients get timely access to care and to have a better relationship with their doctor.
Share: VANCOUVER, British Columbia, May 13, 2021 (GLOBE NEWSWIRE) -- Canadian patients are waiting, on average, more than 450 days longer than Americans and Europeans to access new, potentially life-saving drugs, finds a new study released today by the Fraser Institute, an independent, non-partisan, Canadian public policy think-tank. "Innovative new medicines can have a profound impact on the health and wellbeing of those suffering from illness. Unfortunately, Canadians are often denied these benefits for months, if not years, waiting for government to approve drugs already deemed safe and ...